• Revelation Biosciences adopted a stockholder rights plan, issuing one right per common share via a dividend.
• Rights payable to holders of record on July 21, 2026.
• Rights become exercisable if an investor group crosses 10% ownership, or 15% for certain passive institutional investors.
• Each right allows purchase of 1/1,000 of Series B Junior Participating Preferred Stock at an exercise price of $20.
• Rights expire July 10, 2027 unless stockholders approve, extending the term to three years from approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revelation Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607101605ACCESSWRNAPR_____1189185) on July 10, 2026, and is solely responsible for the information contained therein.